Electra Therapeutics, Inc.
NASDAQElectra Therapeutics arrived on the public markets last week with an unusually active register: a 13D activist filing from its largest shareholder, $20 million in disclosed open-market buying at the IPO price, and a stock already trading 17% below where insiders put their money just nine days ago. The ownership story is the most consequential fact about ETRA right now. OrbiMed…
Snapshot as of 30 Sept 2026
Electra Therapeutics arrived on the public markets last week with an unusually active register: a 13D activist filing from its largest shareholder, $20 million in disclosed open-market buying at the IPO price, and a…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ETRA — free to start on ORTEX.
Sign up for free →Open ETRA on ORTEX